Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?

No hay miniatura disponible
Aguilar L.A.
Coveñas R.
Díaz-Cabiale Z.
Manso B.
Medina L.E.
Narváez J.A.
Sánchez M.L.
Título de la revista
Revista ISSN
Título del volumen
Elsevier (Singapore) Pte Ltd
Proyectos de investigación
Unidades organizativas
Número de la revista
Glucose-6-phosphate dehydrogenase (G6PD) is a cytoplasmic enzyme with an important function in cell oxidative damage prevention. Erythrocytes have a predisposition towards oxidized environments due to their lack of mitochondria, giving G6PD a major role in its stability. G6PD deficiency (G6PDd) is the most common enzyme deficiency in humans; it affects approximately 400 million individuals worldwide. The overall G6PDd allele frequency across malaria endemic countries is estimated to be 8%, corresponding to approximately 220 million males and 133 million females. However, there are no reports on the prevalence of G6PDd in Andean communities where bartonellosis is prevalent.
Palabras clave
glucose 6 phosphate dehydrogenase, Andean, Bartonella bacilliformis, Carrion disease, cell invasion, disease association, endemic disease, enzyme activity